Hansa Biopharma Partners With Cradle on AI Protein Design
Hansa Biopharma is partnering with Cradle to use AI for protein design and engineering across its drug discovery pipeline, the companies announced in a press release. The work will focus on therapeutic candidates for severe autoimmune diseases.
Hansa will use Cradle's platform for tasks including candidate identification, design and optimization. The system can optimize proteins across multiple parameters and learn from Hansa's experimental data to inform subsequent laboratory work.
The partnership expands Hansa's use of AI in research for immunomodulatory therapies. Cradle says its platform is used in more than 80 active research and development programs across pharmaceuticals, industrial biology, agriculture and consumer goods.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 1 Codoxo Named to TIME's 2026 Health Tech Ranking Sep 30 LateralCare brings revenue alai to Microsoft Marketplace Sep 30 NYU Langone Tests AI Tool to Fill Radiology Training Gaps Sep 30 Healthcare Triangle Plans North American Humanoid Nursing Robot Venture Sep 30 Xtalks Plans Webinar on AI Governance in Clinical DevelopmentLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Novo Nordisk Partners With Anthropic on Drug Research
AbbVie Partners With Valkai on AI Tools for Clinical Development
CAS and Novartis Partner on Reaction Data for AI Research
Tsingke Introduces Validation Workflow for AI Designed Proteins
Daily AI Brief: the AI news that matters, in your inbox.